CIK: 0001400240
Total reported value
$1.2B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MRNA | Moderna INC | Stock-Healthcare | 51.21% | -21.90% | — | |
| 2 | RUBYUSD | Rubius Therapeutics INC | Stock-Other | 16.45% | — | — | |
| 3 | KLDO | Kaleido Biosciences INC | Stock-Other | 7.15% | — | — | |
| 4 | DNLI | Denali Therapeutics INC | Stock-Other | 6.71% | — | — | |
| 5 | ✓ | Evelo Biosciences INC | Stock-Other | 6.08% | — | — | |
| 6 | MCRB1EUR | Seres Therapeutics INC | Stock-Other | 4.73% | — | — | |
| 7 | TMDX | Transmedics Group INC | Stock-Healthcare | 3.29% | — | — | |
| 8 | ✓ | Axcella Health INC Com New | Stock-Other | 2.71% | — | — | |
| 9 | SYRSEUR | Syros Pharmaceuticals INC | Stock-Other | 1.67% | — | -8.30% | |
| 10 | QTRX | Quanterix CORP | Stock-Other | — | — | -100.00% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | MRNA | Moderna INC | +13.9% | — | Unchanged |
| 2 | MCRB1EUR | Seres Therapeutics INC | +1.7% | — | Unchanged |
| 3 | SYRSEUR | Syros Pharmaceuticals INC | +0.4% | -8.30% | Trim |
| 4 | TMDX | Transmedics Group INC | +0.1% | — | Unchanged |
| 5 | DNLI | Denali Therapeutics INC | -0.5% | — | Unchanged |
| 6 | ✓ | Axcella Health INC Com New | -0.8% | — | Unchanged |
| 7 | ✓ | Evelo Biosciences INC | -1% | — | Unchanged |
| 8 | KLDO | Kaleido Biosciences INC | -1.6% | — | Unchanged |
| 9 | QTRX | Quanterix CORP | -2.7% | EXIT | Sold out |
| 10 | RUBYUSD | Rubius Therapeutics INC | -9.6% | — | Unchanged |